Absolute decrease in regulatory T cells and low-dose interleukin-2 therapy: restoring and expanding regulatory T cells to treat systemic sclerosis: a 24-week study.

Yu, Zhen; Cheng, Hao; Ding, Tingting; Liang, Yuying; Yan, Chenglan; Gao, Chong; Wen, Hongyan

Yu, Zhen; Cheng, Hao; Ding, Tingting; Liang, Yuying; Yan, Chenglan; Gao, Chong; Wen, Hongyan.

Afiliación

Yu Z; Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, China.
Cheng H; Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, China.
Ding T; Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, China.
Liang Y; Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, China.
Yan C; Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, China.
Gao C; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Wen H; Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, China.

Clin Exp Dermatol ; 47(12): 2188-2195, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36184784

Asunto(s)

Interleucina-2; Esclerodermia Sistémica; Linfocitos T Reguladores; Humanos; Interleucina-2/uso terapéutico; Esclerodermia Sistémica/tratamiento farmacológico; Subgrupos de Linfocitos T; Células Th17

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Interleucina-2 / Linfocitos T Reguladores Límite: Humans Idioma: En Revista: Clin Exp Dermatol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google